You just read:

CeNeRx Announces FDA IND Approval for its Neuroprotective Agent in Chemotherapy-Induced Neuropathy and Results From First Human Study

News provided by

CeNeRx BioPharma, Inc.

Feb 09, 2011, 07:30 ET